Edition:
India

CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

53.25USD
11:33pm IST
Change (% chg)

$-0.27 (-0.50%)
Prev Close
$53.52
Open
$53.43
Day's High
$53.43
Day's Low
$52.83
Volume
747,624
Avg. Vol
2,675,404
52-wk High
$82.12
52-wk Low
$51.72

Latest Key Developments (Source: Significant Developments)

CVS Health CFO Says Drug Price Inflation Was Consistent With Original Expectations
Wednesday, 1 May 2019 

May 1 (Reuters) - CVS Health Corp ::SAYS TRACKING TO THE HIGHER END OF THE $300 MILLION TO $350 MILLION SYNERGY COST GOAL FOR 2019 FROM AETNA DEAL.CVS SAYS IT PLANS TO PARTICIPATE IN GOVERNMENT'S TRIAL PROGRAM AIMED AT TESTING CHANGES TO PRESCRIPTION PLAN REBATES: CONF. CALL.CVS HEALTH CFO SAYS DRUG PRICE INFLATION REMAINED CONSISTENT WITH ORIGINAL EXPECTATIONS.CVS CFO SAYS ON TRACK TO EXCEED COST SAVINGS TARGET FROM AETNA DEAL OF $750 MILLION IN 2020.CVS EXPECTS TO GENERATE DEAL RELATED ANNUAL SAVINGS OF $1.5 BILLION TO $2 BILLION IN 2022.  Full Article

CVS Health Reports Q1 GAAP Earnings Per Share Of $1.09
Wednesday, 1 May 2019 

May 1 (Reuters) - CVS Health Corp ::CVS HEALTH REPORTS FIRST QUARTER RESULTS.Q1 ADJUSTED EARNINGS PER SHARE $1.62.Q1 GAAP EARNINGS PER SHARE $1.09.Q1 EARNINGS PER SHARE ESTIMATE $1.50 -- REFINITIV IBES DATA.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $6.75 TO $6.90.SEES Q2 2019 ADJUSTED EARNINGS PER SHARE $1.68 TO $1.72.SEES Q2 2019 GAAP EARNINGS PER SHARE $1.20 TO $1.24.SEES FY 2019 GAAP EARNINGS PER SHARE $4.90 TO $5.05.REVISED 2019 GAAP OPERATING INCOME GUIDANCE RANGE TO $11.8 BILLION TO $12.0 BILLION FROM $11.7 BILLION TO $12.1 BILLION.CONFIRMED 2019 CASH FLOW FROM OPERATIONS GUIDANCE RANGE OF $9.8 BILLION TO $10.3 BILLION.QTRLY SAME STORE SALES INCREASE 3.8 % VERSUS RISE OF 5.8 %.CVS HEALTH - FRONT STORE REVENUE INCREASED IN THREE MONTHS ENDED MARCH 31, COMPARED TO PRIOR YEAR PRIMARILY DRIVEN BY INCREASES IN HEALTH PRODUCT SALES.CVS HEALTH - NARROWED & RAISED MID-POINT OF GUIDANCE RANGE FOR FY ADJUSTED OPERATING INCOME TO $15.0 BILLION TO $15.2 BILLION FROM $14.8 BILLION TO $15.2 BILLION.FY2019 EARNINGS PER SHARE VIEW $6.77, REVENUE VIEW $251.62 BILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE VIEW $1.67, REVENUE VIEW $62.52 BILLION -- REFINITIV IBES DATA.QTRLY REVENUES $61,646 MILLION VERSUS $45,743 MILLION.Q1 REVENUE VIEW $60.39 BILLION -- REFINITIV IBES DATA.CVS HEALTH - QTRLY REVENUE GROWTH DRIVEN BY AETNA DEAL, INCREASED VOLUME, BRAND NAME DRUG PRICE INFLATION IN PHARMACY SERVICES, RETAIL/LTC SEGMENTS.  Full Article

CVS Health Says CEO Larry Merlo's FY 2018 Total Compensation Was $21.9 Mln
Saturday, 6 Apr 2019 

April 5 (Reuters) - CVS Health Corp ::CVS HEALTH SAYS CEO LARRY MERLO'S FY 2018 TOTAL COMPENSATION WAS $21.9 MILLION VERSUS $12.3 MILLION IN FY 2017 - SEC FILING.CVS HEALTH CORP SAYS COO JONATHAN ROBERTS' FY 2018 TOTAL COMPENSATION WAS $16.1 MILLION VERSUS $6.9 MILLION IN FY 2017.CVS HEALTH CORP SAYS RATIO OF CEO ANNUAL COMPENSATION TO MEDIAN EMPLOYEE FOR 2018 IS 618-TO-1.  Full Article

U.S. Senate Finance Committee's Grassley, Wyden Invite 5 PBMS To Drug Pricing Hearing
Wednesday, 13 Mar 2019 

March 12 (Reuters) - U.S. Senate Finance Committee::GRASSLEY, WYDEN INVITE 5 PHARMACY BENEFIT MANAGERS TO DRUG PRICING HEARING ON APRIL 3.COS INVITED INCLUDE CIGNA CORPORATION, CVS CAREMARK & CVS HEALTH CORPORATION, HUMANA INC, OPTUMRX & PRIME THERAPEUTICS.  Full Article

Aetna Enters Into Agreement With Healthy Business Group
Tuesday, 29 Jan 2019 

Jan 28 (Reuters) - Healthy Business Group::AETNA ENTERS INTO AGREEMENT WITH HEALTHY BUSINESS GROUP.HEALTHY BUSINESS GROUP- CO, AETNA ANNOUNCED AGREEMENT THAT OFFERS HBG'S PORTFOLIO OF HEALTH,WELL-BEING SOLUTIONS TO AETNA'S MEMBERS IN NY & NEW JERSEY.  Full Article

Ritzman Pharmacy To Sell Pharmacy Business To Cvs Pharmacy
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Ritzman Pharmacies Inc::PRESS RELEASE - RITZMAN PHARMACY TO SELL PHARMACY BUSINESS TO CVS PHARMACY.RITZMAN PHARMACY TO SELL PHARMACY BUSINESS TO CVS PHARMACY.RITZMAN PHARMACIES INC - ANNOUNCED THAT IT PLANS TO SELL ITS 20 RETAIL PHARMACIES TO CVS PHARMACY.RITZMAN PHARMACIES - CVS PHARMACY PLANS TO OPERATE IN SAME LOCATIONS WITH SAME STAFF IN AKRON AND BERLIN STORES.  Full Article

Cvs Health Sets Quarterly Dividend Of $0.50Per Share
Thursday, 3 Jan 2019 

CVS Health Corp ::SETS QUARTERLY DIVIDEND OF $0.50PER SHARE.  Full Article

CVS Health Says Savings From Aetna Transaction May Exceed $750 Mln- Conf. Call
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - Cvs Health Corp ::SAYS SAVINGS FROM AETNA TRANSACTION MAY EXCEED $750 MILLION- CONF. CALL.SAYS HAS REACHED AGREEMENT WITH CALIFORNIA STATE REGULATOR ON AETNA DEAL AND IS FINALIZING TERMS.  Full Article

CVS Health Reports Q3 GAAP EPS From Continuing Operations Of $1.36
Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - CVS Health Corp ::Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36 .CVS HEALTH CORP QTRLY NET REVENUES INCREASED 2.4% TO $47.3 BILLION.CVS HEALTH CORP QTRLY ADJUSTED EPS OF $1.73.CVS HEALTH CORP SEES 2018 GAAP DILUTED EPS FROM CONTINUING OPERATIONS OF $1.40 TO $1.50.CVS HEALTH CORP SEES 2018 ADJUSTED EPS OF $6.98 TO $7.08.CVS HEALTH CORP SEES 2018 CASH FLOW FROM OPERATIONS OF ABOUT $9.0 BILLION; FREE CASH FLOW OF APPROXIMATELY $7.0 BILLION.CONFIRMED FULL YEAR GUIDANCE.CVS HEALTH CORP QTRLY SAME STORE SALES INCREASED 6.7% AND PHARMACY SAME STORE SALES INCREASED 8.7% IN THE QUARTER ENDED SEPT 30, 2018.FRONT STORE SAME STORE SALES INCREASED 0.8% IN THE QUARTER ENDED SEPT 30, 2018, COMPARED TO THE SAME QUARTER OF THE PRIOR YEAR.Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36.REGULATORY APPROVAL PROCESS FOR AETNA DEAL IS PROCEEDING WITHIN TIMEFRAME CONSISTENT WITH EXPECTATIONS.IN Q2 CO HAD $3.9 BILLION GOODWILL IMPAIRMENT CHARGE RELATED TO LTC BUSINESS.  Full Article

Teamsters Local 727 Resumes Negotiations With CVS For A New Collective Bargaining Agreement
Wednesday, 26 Sep 2018 

Sept 26 (Reuters) - TEAMSTERS LOCAL 727 ::TEAMSTERS LOCAL 727 - CVS, TEAMSTERS LOCAL 727 RESUMED NEGOTIATIONS FOR A NEW COLLECTIVE BARGAINING AGREEMENT SEPT. 21.TEAMSTERS LOCAL 727 SAYS IT FILED LABOR PRACTICE CHARGE AGAINST CVS OVER ITS DELAY TO RESPOND THAT IS PENDING WITH NATIONAL LABOR RELATIONS BOARD.  Full Article

Photo

U.S. judge calls hearing on merger of CVS and Aetna: court filing

WASHINGTON A federal judge on Monday ordered up to three days of hearings next month to consider CVS Health Corp's $69 billion merger with Aetna, which has closed but must still get court approval.